Cannabis Global, Inc.: Cannabis Global Files Patent on Animal-Based Cannabosides - A New Form of Animal Processed Cannabinoids for Food and Beverages

LOS ANGELES, CA / ACCESSWIRE / January 19, 2021 / Cannabis Global, Inc. (OTC PINK:CBGL), an innovation-oriented company investing in disruptive cannabis and hemp-related technologies, today announces the filing of a new patent on a unique method to produce water-soluble cannabinoids. The patent announced today relates to a composition comprising one or more cannabosides and a method of producing one or more cannabosides. In particular, by feeding an insect a cannabinoid and harvesting the insect, excluding honey bees, to improve aqueous solubility and stability of cannabinoids. The patent claims coverage of both the process to create the compounds, and the use of the compounds in foodstuffs and pharmaceutical preparations.

Cannabinoids are basically oil and thus hydrophobic, meaning these don't mix well with water. Of course, the human body is mainly made of water. In the most simple of terms, this issue of cannabinoids being oils and our bodies being made mostly of water presents a significant challenge relative to formulation and delivery for the cannabis and pharmaceutical industries.

"Our corporate research program was specifically designed to address issues relating to the absorption of cannabinoids," commented Arman Tabatabaei, CEO of Cannabis Global. "The results have been the filing of three patents on cannabinoid delivery technologies, two of which specifically address using life forms to process and alter cannabinoids. We believe what we have invented represents a new form of cannabinoids processing with a host of positive implications for cannabinoid delivery in foods, beverages and pharmaceuticals."

This most recent patent application is the Company's third non-provisional filing after six provisional applications were filed during 2019 and 2020. In November 2020, the Company filed to protect its novel methods for creation and use of polymeric cannabinoid nanoparticles, including methods to create such particles using food-grade ingredients. During December 2020, Cannabis Global filed its non-provisional patent on unique methods to create powdered cannabinoids for use in foods, beverages and pharmaceuticals, including the use of specific methods of utilizing insects, excluding honey bees.

About Cannabis Global, Inc.
Cannabis Global, Inc., formerly known as MCTC Holdings, Inc., is a fully audited and reporting Company with the U.S. Securities & Exchange Commission, trading with the stock symbol CBGL. The Company is an emerging force in the area of cannabinoid sciences and highly bioavailable hemp and cannabis infusion technologies. The Company does not engage in the production, distribution, or sales of any controlled substances, including marijuana. The Company has an actively growing portfolio of intellectual property having filed six patents in the areas of cannabinoid delivery systems and cannabinoid polymeric nanoparticles. The Company markets its consumer products under the Hemp You Can Feel brand name. Cannabis Global launched its Project Varin early in 2020, to develop new delivery methods for rare cannabinoid Tetrahydrocannabivarin (THV-C) and to develop products based on this cannabinoid.

Forward-Looking Statements
This news release contains "forward-looking statements" which are not purely historical and may include any statements regarding beliefs, plans, expectations or intentions regarding the future. Such forward-looking statements include, among other things, the development, costs and results of new business opportunities and words such as "anticipate", "seek", intend", "believe", "estimate", "expect", "project", "plan", or similar phrases may be deemed "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Actual results could differ from those projected in any forward-looking statements due to numerous factors. Such factors include, among others, the inherent uncertainties associated with new projects, the future U.S. and global economies, the impact of competition, and the Company's reliance on existing regulations regarding the use and development of cannabis-based products. These forward-looking statements are made as of the date of this news release, and we assume no obligation to update the forward-looking statements, or to update the reasons why actual results could differ from those projected in the forward-looking statements. Although we believe that any beliefs, plans, expectations and intentions contained in this press release are reasonable, there can be no assurance that any such beliefs, plans, expectations or intentions will prove to be accurate. Investors should consult all of the information set forth herein and should also refer to the risk factors disclosure outlined in our annual report on Form 10-k, our quarterly reports on Form 10-Q and other periodic reports filed from time-to-time with the Securities and Exchange Commission. For more information, please visit:www.sec.gov

For more information, please contact:
Arman Tabatabaei
[e-mail]
[phone]

IR Contact:
Stuart Smith
https://www.smallcapvoice.com/
[e-mail]

SOURCE: Cannabis Global, Inc.

View source version on accesswire.com:
https://www.accesswire.com/624781/Cannabis-Global-Files-Patent-on-Animal-Based-Cannabosides--A-New-Form-of-Animal-Processed-Cannabinoids-for-Food-and-Beverages